Pharmacogenomics and Personalized Medicine
Volume 12, 2019 - Issue
Original Research
CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese
Elaine Chow1 Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong;2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong KongCorrespondence[email protected]
https://orcid.org/0000-0002-4147-3387
https://orcid.org/0000-0002-4147-3387, , , Juliana CN Chan2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Konghttps://orcid.org/0000-0003-1325-1194
https://orcid.org/0000-0003-1325-1194 & Brian Tomlinson1 Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong;2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong;3 Faculty of Medicine, Macau University of Science & Technology, Taipa, Macauhttps://orcid.org/0000-0001-6717-5444
https://orcid.org/0000-0001-6717-5444